-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid);
LUVs: large unilamellar vesicles; PGON: polyguanidino-oxanorbornene; Tris:
tris(hydroxymethyl)aminomethane.
Synthesis of Transporters
The synthesis of PGONs starts with the TFA salt of 1 from Scheme 1 in the text. S1 To this Final deprotected polymers were protected from moisture and stored at -20 ºC.
Gel permeation chromatography (GPC) was performed on the Boc-protected polymers with a Polymer Lab LC1120 pump equipped with a Waters differential refractometer detector.
The mobile phase was tetrahydrofuran with a flow rate of 1.0 mL/min. 176.3, 156.6, 153.0, 136.5, 83.3, 80.9, 47.6, 39.0, 38.4, 28.3, 28 
Synthesis of Inactivators
Cascade Blue Hydrazide (CB Hydrazide). 
S5

Activity, Activators and Inactivators (EYPC-LUVs CF)
Preparation of EYPC-LUVs CF. S3 A thin lipid film was prepared by evaporating a solution of 25 mg EYPC in 1 ml MeOH/CHCl 3 (1:1) on a rotary evaporator (40 °C) and then in vacuo overnight. After hydration (> 30 min) with 1.0 ml buffer (10 mM Tris, 10 mM NaCl, 50 mM CF, pH 7.5), the resulting suspension was subjected to >5 freeze-thaw cycles (liquid N 2 , 40 °C water bath), and >15 times extruded through a polycarbonate membrane (pore size 100 nm). Extravesicular components were removed by size exclusion chromatography (Sephadex G-50, Sigma-Aldrich) with 10 mM Tris, 107 mM NaCl, pH 7.5. Final conditions:
~2.5 mM EYPC; inside: 10 mM Tris, 10 mM NaCl, 50 mM CF, pH 7.5; outside: 10 mM Tris, 107 mM NaCl, pH 7.5. triton X-100 at the end of every experiment. Time courses of I t were normalized to fractional intensities I f using equation S1. Pyrene Excimers. Aqueous solutions of pyrenebutyrate were prepared by addition of 1 equivalent of NaOH to pyrenebutyric acid in water. Solutions of pyrenebutyrate (120 µM)
PGON Activity in EYPC-
I f = (I t -I 0 ) / (I -I 0 )(S1)Y = Y + (Y 0 -Y ) / {1 + c PGON / EC 50 ) n } (S2)Y f = (Y -Y 0 ) / (Y -Y 0 )(S3)Y f = Y ,f + (Y 0,f -Y ,f ) / {1 + c I / IC 50 ) n } (S4)
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in buffer (2 ml, 10 mM Na m H n PO 4 , pH 7.4) with N14, N41 or polyarginine (0 -50 µl of concentrated stock solutions) were gently mixed, and the fluorescence emission spectra were measured with ex 340 nm. The obtained spectra were normalized at 375 nm, and fractional excimer emission intensities at 470 nm (I 470 / I 375 ) were plotted as a function of polymer concentration and subjected to Hill analysis ( Figure S1 ). 
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Dependence on Membrane Fluidity (DPPC-LUVs CF)
Preparation of DPPC-LUVs CF. S5 A thin lipid film was prepared by evaporating a solution of 25 mg DPPC in 1 ml MeOH/CHCl 3 (1:1) on a rotary evaporator (40 °C) and then in vacuo overnight. After hydration (> 30 min) with 1.0 ml buffer (10 mM Tris, 10 mM NaCl, 50 mM CF, pH 7.5) at 60 °C (which is well above the phase transition temperature) S6 the resulting suspension was subjected to >5 freeze-thaw cycles (liquid N 2 , 60 °C water bath).
The extruder was assembled and placed on top of a hot plate to warm up to 60 °C, which was controlled by measuring the temperature inside the heating block. The vesicle suspension was >15 times extruded through a polycarbonate membrane (pore size 100 nm) and extravesicular components were subsequently removed by size exclusion chromatography (Sephadex G-50, Sigma-Aldrich) with 10 mM Tris, 107 mM NaCl, pH 7.5. Final conditions: ~2.5 mM DPPC;
inside: 10 mM Tris, 10 mM NaCl, 50 mM CF, pH 7.5; outside: 10 mM Tris, 107 mM NaCl, pH 7.5. activity Y was performed as described above for EYPC-LUVs CF.
PGON Activity in DPPC-
Dependence on Surface Potentials (EYPC/EYPG-LUVs CF)
Preparation of EYPC/EYPG-LUVs CF. Thin lipid film were prepared by evaporating a 1 ml MeOH/CHCl 3 (1:1) solution of 25 mg lipids in molar ratios 10:0, 9:1, 7:3, and 1:1 of EYPC and EYPG on a rotary evaporator (40 °C) and then in vacuo overnight. After hydration (> 30 min) with 1.0 ml buffer (10 mM Tris, 10 mM NaCl, 50 mM CF, pH 7.5), the resulting suspension was subjected to >5 freeze-thaw cycles (liquid N 2 , 40 °C water bath), and >15 times extruded through a polycarbonate membrane (pore size 100 nm). Extravesicular components were removed by size exclusion chromatography (Sephadex G-50, Sigma-
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Aldrich) with 10 mM Tris, 107 mM NaCl, pH 7.5. Final conditions: ~2.5 mM EYPC; inside:
10 mM Tris, 10 mM NaCl, 50 mM CF, pH 7.5; outside: 10 mM Tris, 107 mM NaCl, pH 7.5.
PGON Activity in EYPC/EYPG-LUVs CF. 25 µl of each lipid preparation were
added to 1975 µl gently stirred, thermostated buffer (10 mM Tris, 107 mM NaCl, pH 7.5) in a disposable plastic cuvette. The time-dependent change in fluorescence intensity I t ( exc = 492 nm, em = 517 nm) was monitored during the addition of PGON14 (20 µl stock solution in DMSO, 1 nM -100 µM final concentration) at t = 0 min, and addition of 40 µl 1.2 % (aq.) triton X-100 at the end of every experiment. Time courses of I t were normalized to fractional intensities I f and analyzed using equations S1 and S2 as described above.
Dependence on Membrane Potentials (EYPC-LUVs ANTS/DPX)
Preparation of EYPC-LUVs ANTS/DPX. S7 A thin lipid film was prepared by evaporating a solution of 25 mg EYPC in 1 ml MeOH/CHCl 3 (1:1) on a rotary evaporator and then in vacuo overnight. After hydration (> 30 min) with 1.0 ml buffer (10 mM Hepes, 20 mM KCl, 12.5 mM ANTS, 45 mM DPX, pH 7.5), the resulting suspension was subjected to >5 freeze-thaw cycles (liquid N 2 , 40 °C water bath), and >15 times extruded through a polycarbonate membrane (pore size 100 nm). Extravesicular components were removed by size exclusion chromatography (Sephadex G-50, Sigma-Aldrich) with 10 mM Hepes, 100 mM NaCl, pH 7.5. Final conditions: ~2.5 mM EYPC; inside: 10 mM Hepes, 20 mM KCl, 12.5 mM ANTS, 45 mM DPX, pH 7.5; outside: 10 mM Hepes, 100 mM NaCl, pH 7.5.
Membrane Polarization. using equations S1 and S2 as described above.
Lactate Sensing
S3
Detection of Enzyme Activity. 20 µl of 50 mM (L)-lactate in H 2 O (adjusted to pH 6.5
with NaOH), 10 µl of 22000 U/ml catalase in H 2 O, and 10 µl lactate oxidase (0, 10, and 50 U/ml in H 2 O) were added to 160 µl 50 mM Na 2 HPO 4 (pH 6.5) at 37 °C. Final concentrations:
5 mM (L)-lactate; 1100 U/ml catalase; 0, 0.5, and 2.5 U/ml lactate oxidase. Aliquots (5 µl) of the reaction mixture were withdrawn after defined time intervals and diluted with 20 µl 0.4 M NaOAc/HOAc, pH 4.5. 25 µl of CB hydrazide stock solution (1 mM) in DMSO was added and the reaction mixture was incubated for 30 min at 50 °C. 20 µl aliquots were subjected to fluorescence analysis as described above (cf. paragraph 5, equation S3).
Sensor Calibration. x (0.1 to 30) µl of 100 mM (L)-lactate in H 2 O (adjusted to pH 6.5
with NaOH), 5 µl of 22000 U/ml catalase in H 2 O, and 5 µl lactate oxidase (50 U/ml in H 2 O)
were mixed with 90-x µl 50 mM Na 2 HPO 4 (pH 6.5) at 37 °C for 60 min (concentration of lactate in the reaction mixture c rx = 0.1 -30 mM). Aliquots (5 µl) of the reaction mixture were withdrawn after defined time intervals and diluted with 20 µl 0.4 M NaOAc/HOAc, pH S11 
The obtained c rx = 1.8 ± 0.3 mM can be related to the IC 50 by considering 10x dilution during derivatization and 100x dilution during transduction. This gives an IC 50 = 1.8 ± 0.3 µM which is in excellent agreement with the IC 50 = 1.5 ± 0.1 µM of pyruvate.
Determination of Lactate Content in Sour
Milk. Sour milk (Valflora M-Dessert, Migros, CH) was centrifuged twice for 2 min at 14500 rpm. The upper, white phase was removed, and the lower, clear phase (milk serum) was filtered through glass wool. The filtered serum (source phase) was dialyzed against 1 ml 50 mM KH 2 PO 4 , pH 6.5 (receiving phase) for 3 h (cut off = 5 kDa), followed by the replacement of the source phase with fresh serum, and further dialysis for 16 h (total: 1.33fold dilution). The pH of the receiving phase was carefully controlled and remained constant during dialysis. Subsequently, x µl (initial volume V i ) of the receiving phase, 5 µl of 22000 U/ml catalase in H 2 O, and 5 µl lactate oxidase (50 U/ml in H 2 O) were mixed with 90-x µl 50 mM Na 2 HPO 4 (pH 6.5) at 37 °C for 60 min (total volume V 0 = 100 µl). Aliquots (5 µl) of the reaction mixture were withdrawn after 
